Low back pain relief: an evidence-based guide to what actually works
TL;DR
- First-line low back pain relief combines NSAIDs (e.g., ibuprofen, naproxen), superficial heat, and continued physical activity — prolonged bed rest worsens outcomes.
- For chronic lumbar pain lasting 12+ weeks, structured exercise therapy and physical therapy have the strongest evidence; pharmacotherapy is second-line.
- Muscle relaxants, opioids, and invasive procedures have limited roles and carry significant risks — they should be reserved for specific, refractory cases under close supervision.
Understanding low back pain relief: why it matters
Low back pain is one of the most common reasons adults seek medical care worldwide. In the United States alone, chronic low back pain — defined as lumbar pain persisting for 12 weeks or more — affects approximately 13% of adults [7]. The condition is the leading cause of years lived with disability globally, according to the Global Burden of Disease studies [VERIFY]. Despite its prevalence, effective low back pain relief remains elusive for many patients, partly because the underlying cause is often difficult to pinpoint. In the majority of cases, no specific structural or radiographic abnormality can be identified, leading to a diagnosis of "non-specific" low back pain [7][8].
The economic burden is staggering. Direct healthcare costs and indirect losses from missed work make lumbar pain one of the most expensive musculoskeletal conditions in developed countries [VERIFY]. Yet much of the spending goes toward treatments with weak or no evidence behind them — advanced imaging for uncomplicated cases, long-term opioid prescriptions, unnecessary injections, and premature surgery. The American College of Physicians (ACP), the National Institute for Health and Care Excellence (NICE), and other bodies have published guidelines aiming to redirect care toward what the evidence actually supports.
This guide walks through the major pharmacologic and non-pharmacologic strategies for low back pain relief, ranks them by the quality of available evidence, and highlights the red flags that should prompt urgent evaluation rather than self-management.
Acute vs. chronic lumbar pain: setting the clinical stage
Distinguishing acute from chronic lumbar pain is the first step toward appropriate management, because the treatment approach differs substantially.
Acute low back pain (lasting fewer than 4 weeks) is typically self-limiting. About 80–90% of episodes resolve within 6 weeks regardless of treatment [VERIFY]. The primary goals during this phase are pain control, maintaining function, and avoiding treatments that may do more harm than good.
Subacute low back pain (4–12 weeks) represents a transitional period. Patients who are not improving deserve reassessment and may benefit from more structured interventions such as physical therapy.
Chronic low back pain (12 weeks or longer) is a different entity. Central sensitization, multifidus muscle dysfunction, psychosocial factors ("yellow flags"), and deconditioning all contribute to persistence of symptoms [7][8]. Lumbar multifidus dysfunction, in particular, has been increasingly recognized as a contributor to non-specific chronic low back pain; atrophy and fatty infiltration of this deep stabilizing muscle may perpetuate spinal instability and pain cycles [8].
Red flags requiring immediate evaluation
Before pursuing any self-directed low back pain relief strategy, the following warning signs should prompt urgent medical assessment:
- Cauda equina symptoms (saddle anesthesia, bilateral leg weakness, bowel/bladder dysfunction)
- Unexplained weight loss or history of cancer
- Fever with back pain (possible spinal infection)
- Significant trauma (especially in older adults or those on corticosteroids)
- Progressive neurological deficit
- Pain that worsens at night and is unrelieved by position changes
Patients with chronic low back pain should also be assessed for psychological, environmental, and social "yellow flags" that increase the risk of disability, including catastrophizing, fear-avoidance beliefs, workplace dissatisfaction, and pending litigation [7].
Non-pharmacologic therapies: the foundation of low back pain relief
Every major guideline — ACP (2017), NICE (NG59, updated 2020), and the Lancet Low Back Pain Series (2018) — places non-pharmacologic therapy as the first-line approach for both acute and chronic lumbar pain [VERIFY]. This is not a soft recommendation; the evidence base is robust and consistently favors active strategies over passive ones.
Stay active and avoid bed rest
Perhaps the single most important message in modern low back pain management is this: avoid prolonged bed rest. Patients should be counseled to remain as active as tolerated [7]. Bed rest beyond 1–2 days for severe acute pain has been shown to delay recovery, promote deconditioning, and increase the risk of chronicity [VERIFY]. Continued ordinary activities, including walking, are associated with faster return to work and lower rates of disability.
Superficial heat for back pain
Applying heat to the back (heating pads, heat wraps, warm baths) provides modest but meaningful short-term relief for acute lumbar pain. A Cochrane review found that continuous low-level heat wrap therapy reduced pain intensity and disability more effectively than placebo over the first 5 days of an acute episode [VERIFY]. Heat is inexpensive, widely accessible, and carries minimal risk, making it an ideal first-line adjunct. Patients should be advised to use moderate heat (not scalding) for 15–20 minutes at a time and to place a cloth layer between the heat source and the skin to avoid burns.
For chronic lumbar pain, heat back therapy remains a reasonable adjunct but is typically insufficient as a standalone treatment.
Exercise therapy
For chronic low back pain, exercise therapy is the intervention with the broadest and most consistent evidence base. The ACP guideline recommends exercise as a core component of management [VERIFY]. Types of exercise studied include:
- General aerobic exercise (walking, swimming, cycling)
- Core stabilization and motor control exercises — specifically targeting the lumbar multifidus and transversus abdominis. These exercises address the documented multifidus atrophy and dysfunction seen in chronic low back pain [8].
- Yoga and tai chi — moderate-quality evidence supports these for chronic lumbar pain.
- Pilates — some evidence of benefit, though studies are heterogeneous.
No single exercise modality has proven clearly superior to others. The best exercise is often the one the patient will actually perform consistently. Graded sensorimotor retraining, as studied in the RESOLVE trial (a 276-participant RCT), represents an emerging approach that combines education about pain neuroscience with progressive movement retraining. This intervention showed statistically significant reductions in pain intensity compared with a sham/attention-control group at 18 weeks, with effects sustained at one year [5].
Physical therapy
For patients with subacute or chronic lumbar pain who are not improving with self-directed activity and exercise, referral to physical therapy is strongly supported. Physical therapists can provide individualized exercise programs, manual therapy, and education. Spinal manipulation (performed by physical therapists, chiropractors, or osteopathic physicians) has moderate evidence for short-term pain relief in both acute and chronic low back pain [7].
Acupuncture
A 2020 Cochrane systematic review examined acupuncture for chronic non-specific low back pain and found that acupuncture likely results in a small reduction in pain and improvement in function compared with sham acupuncture, and a moderate improvement compared with no treatment [4]. The certainty of evidence ranged from low to moderate. Several clinical guidelines (ACP, NICE) include acupuncture as an option, though it is not universally recommended as a first-line therapy. Patients who choose acupuncture should be informed that the effect size is modest and that it works best as a complement to exercise and self-management.
Transcutaneous electrical nerve stimulation (TENS)
A large systematic review and meta-analysis of 381 RCTs (24,532 participants) found that pain intensity was lower during or immediately after TENS compared with placebo, with a standardized mean difference of −0.96 (95% CI −1.14 to −0.78; moderate-certainty evidence) [1]. The effect did not appear to vary by acute vs. chronic pain status or by diagnosis. While TENS is generally safe and non-invasive, the clinical significance of the effect remains debated, and it should be viewed as an adjunctive modality rather than a primary treatment.
Pharmacologic options for lumbar pain: a comparison
| Treatment | Evidence strength | Typical dose (adults) | Onset | Duration of use | Key considerations |
|---|---|---|---|---|---|
| Ibuprofen (Advil, Motrin) | Strong (ACP, NICE) | 400–600 mg q6-8h; max 2,400 mg/day | 30–60 min | Short-term preferred (≤10 days OTC) | GI and cardiovascular risk; avoid in CKD |
| Naproxen (Aleve) | Strong | 250–500 mg q12h; max 1,250 mg/day | 1–2 h | Short-term preferred | Longer half-life; may have slightly lower CV risk than other NSAIDs |
| Diclofenac topical (Voltaren) | Moderate | Apply 4 g to area qid | Variable | Up to 3 weeks OTC | Lower systemic exposure; local skin irritation |
| Acetaminophen (Tylenol) | Weak/insufficient | 500–1,000 mg q6h; max 3,000 mg/day | 30–60 min | Short- or medium-term | Evidence for LBP is poor; 2015 Lancet review found no benefit over placebo for acute LBP [VERIFY] |
| Cyclobenzaprine (Flexeril) — muscle relaxer | Moderate (acute only) | 5–10 mg tid; max 30 mg/day | 1–2 h | ≤2–3 weeks | Sedation, anticholinergic effects; no evidence for chronic use |
| Tizanidine (Zanaflex) — muscle relaxer | Moderate (acute only) | 2–4 mg tid; max 36 mg/day | 1–1.5 h | Short-term | Hepatotoxicity risk; monitor LFTs; sedation |
| Duloxetine (Cymbalta) | Moderate (chronic) | 60 mg daily | 1–4 weeks | Long-term | FDA-approved for chronic musculoskeletal pain; GI side effects; taper to discontinue |
| Oral corticosteroids | Insufficient | Variable | Days | Short course | Evidence inconclusive for LBP; metabolic side effects [7] |
| Opioids | Weak/negative (chronic) | Variable | 15–60 min | Avoid long-term | Risk of dependence, hyperalgesia; ACP and NICE recommend against long-term opioid use for chronic LBP |
NSAIDs are the initial medication of choice for both acute and chronic low back pain when pharmacotherapy is needed [7]. They should be used at the lowest effective dose for the shortest duration necessary. Patients with gastrointestinal risk factors should receive gastroprotection (e.g., a proton pump inhibitor) or use topical formulations.
A muscle relaxer for back pain — most commonly cyclobenzaprine or tizanidine — may provide short-term benefit in acute low back pain when muscle spasm is a prominent feature. However, evidence does not support their use beyond 2–3 weeks, and their side-effect profile (drowsiness, dizziness, dry mouth) limits tolerability [7]. They should not be combined with other CNS depressants. The term "muscle relaxer back" pain treatment is frequently searched by patients, but clinicians should emphasize that these agents address symptoms, not the underlying cause.
Duloxetine is the only antidepressant with consistent evidence and FDA approval for chronic musculoskeletal pain, including chronic low back pain. Other antidepressants (tricyclics, SSRIs) lack robust evidence for this indication [7].
When conservative treatment fails: interventional and surgical options
Most patients with low back pain — even chronic low back pain — will not require surgery [7]. However, a subset of patients with identifiable structural pathology or refractory symptoms may be candidates for interventional procedures.
Epidural corticosteroid injections
These are not recommended for non-specific chronic low back pain. However, they may offer short-term symptom relief (weeks to a few months) for patients with radicular pain (sciatica) from disc herniation [7]. The benefit is temporary, and repeated injections carry risks including infection, dural puncture, and rare neurological complications.
Facet joint interventions
Facet joint osteoarthritis is the most common form of facet joint syndrome and is diagnosed when controlled diagnostic blocks with local anesthetic produce significant (≥75–80%) pain relief [2]. Treatment options include radiofrequency denervation (ablation) of the medial branch nerves, which provides longer-lasting but still temporary relief. The duration of pain relief from radiofrequency neurotomy varies, and recent research has turned toward targeting dorsal roots and facet joint capsules directly [2].
Sacroiliac joint pain
The sacroiliac joint may be responsible for up to 30% of chronic low back pain cases [6]. Diagnosis is confirmed by image-guided anesthetic injection into the joint, with ≥75% symptom relief considered positive [6]. Treatment begins with physical therapy and/or intra-articular steroid injection; radiofrequency denervation and sacroiliac fusion are reserved for refractory cases [6].
Surgery
Indications for surgery in low back pain are narrow: cauda equina syndrome (emergency), progressive neurological deficit, and carefully selected cases of lumbar disc herniation or spinal stenosis with radiculopathy that have failed adequate conservative management (typically ≥6 weeks). For non-specific low back pain without structural pathology, surgery is not indicated.
Adverse effects and safety of common low back pain treatments
| Adverse effect | Associated treatment | Approximate frequency | Recommended action |
|---|---|---|---|
| GI bleeding / ulceration | Oral NSAIDs (ibuprofen, naproxen) | 1–4% per year with chronic use | Use lowest dose, shortest duration; add PPI if risk factors present; consider topical NSAID |
| Cardiovascular events (MI, stroke) | Oral NSAIDs (especially at high doses) | Small absolute increase | Avoid in uncontrolled HTN, heart failure, established CVD; naproxen may carry lower CV risk |
| Hepatotoxicity | Acetaminophen (overdose), tizanidine | Dose-dependent (acetaminophen); uncommon (tizanidine) | Do not exceed 3 g/day acetaminophen; monitor LFTs with tizanidine |
| Sedation / cognitive impairment | Muscle relaxers (cyclobenzaprine, tizanidine), opioids | Very common (30–50%) | Warn about driving/operating machinery; avoid combining with alcohol or benzodiazepines |
| Opioid dependence / misuse | Opioids (any) | Risk increases substantially after >7 days of use | Avoid long-term use; use only when other options have failed; reassess frequently |
| Serotonin syndrome | Duloxetine (especially with tramadol or triptans) | Rare | Avoid combining serotonergic agents; educate on symptoms (agitation, hyperthermia, clonus) |
| Skin irritation | Topical diclofenac, heat wraps, TENS electrodes | Common (10–20% for topical NSAIDs) | Rotate application sites; discontinue if rash develops |
| Nausea / dizziness | Duloxetine (initiation), NSAIDs | Common at start (20–30% duloxetine) | Start duloxetine at 30 mg for 1 week before increasing; take NSAIDs with food |
| Renal impairment | NSAIDs (chronic use), especially with ACE inhibitors/ARBs/diuretics | Uncommon but serious | Monitor creatinine in at-risk patients; avoid "triple whammy" combination |
Special populations and clinical pearls
Pregnancy-related low back and pelvic girdle pain
Pelvic girdle pain (PGP) affects approximately 20% of pregnant women at any given point and can occur separately or in conjunction with low back pain [3]. Risk factors include a history of previous low back pain and prior pelvic trauma. Notably, oral contraceptive use, height, weight, smoking, and age are not established risk factors for PGP in pregnancy [3].
Management in pregnancy is constrained by medication safety:
- Acetaminophen remains the analgesic of choice in pregnancy, despite its limited efficacy for low back pain in the general population.
- NSAIDs are generally avoided after 20 weeks' gestation due to the risk of premature ductus arteriosus closure and oligohydramnios (FDA warning, 2020).
- Physical therapy, exercise, and pelvic support belts are the mainstays of treatment for pregnancy-related PGP [3].
- Pain provocation tests (P4/thigh thrust, Patrick's FABER, Gaenslen's test) can help diagnose PGP specifically [3].
Older adults
Older adults are at higher risk of NSAID-related GI bleeding, cardiovascular events, and renal impairment. Topical NSAIDs (diclofenac gel) are preferred over oral formulations when feasible. Muscle relaxers should be used cautiously due to anticholinergic effects and fall risk. The Beers Criteria list cyclobenzaprine as potentially inappropriate in adults ≥65 years [VERIFY].
Multifidus-targeted rehabilitation
Emerging evidence highlights lumbar multifidus muscle dysfunction — characterized by atrophy and fatty infiltration — as a perpetuating factor in chronic non-specific low back pain [8]. Therapeutic approaches targeting the multifidus include motor control exercises and, more recently, restorative neurostimulation. Traditional conservative management (education, NSAIDs, spinal manipulation, physical therapy) aims primarily at pain relief, while motor control exercises specifically seek to restore natural multifidus function [8]. This represents an evolving area where treatment may shift from purely symptomatic to mechanistically targeted.
Practical patient advice
- Move early and often. Walking is the simplest and most accessible form of exercise for lumbar pain.
- Apply heat to the back for 15–20 minutes, several times daily, during acute episodes.
- Use NSAIDs wisely — at the lowest effective dose, for the shortest time, with food.
- Do not request or expect imaging for uncomplicated low back pain. MRI findings (disc bulges, degenerative changes) are common in pain-free individuals and often do not correlate with symptoms.
- Engage with physical therapy if pain persists beyond 4–6 weeks.
- Address psychosocial factors. Stress, poor sleep, and fear of movement are modifiable contributors to chronic pain.
FAQ
Q1: What is the fastest way to get low back pain relief at home? A1: For acute episodes, the combination of an over-the-counter NSAID (e.g., ibuprofen 400 mg or naproxen 220–440 mg) with superficial heat applied to the affected area for 15–20 minutes provides the most rapid relief supported by evidence. Continue light activities such as walking — do not lie in bed all day. If pain is severe and associated with prominent muscle spasm, a short course (≤2 weeks) of a muscle relaxer such as cyclobenzaprine may be added, though sedation is common [7].
Q2: Is a muscle relaxer for back pain better than an NSAID? A2: Not typically. NSAIDs address both pain and inflammation and have stronger evidence for low back pain relief than muscle relaxants [7]. Muscle relaxers primarily reduce the sensation of spasm and cause significant drowsiness. They are sometimes used as an adjunct to NSAIDs in acute low back pain but are not recommended as monotherapy or for chronic use. The two drug classes work through different mechanisms, and in some acute cases a brief combination may be appropriate under medical supervision.
Q3: Should I get an MRI for my back pain? A3: In most cases, no — at least not initially. Routine imaging is not recommended for uncomplicated low back pain without red flags [7]. MRI findings such as disc degeneration, bulges, and facet arthropathy are extremely common in asymptomatic adults and often lead to unnecessary anxiety, further testing, and interventions that do not improve outcomes. Imaging is indicated when red flags are present (e.g., suspected cancer, infection, cauda equina syndrome), when there is a progressive neurological deficit, or when pain does not respond to conservative therapy after an adequate trial.
Q4: Does acupuncture work for chronic low back pain? A4: A Cochrane systematic review found that acupuncture likely produces a small reduction in pain and a moderate improvement compared with no treatment for chronic non-specific low back pain [4]. The effects compared with sham acupuncture are smaller, suggesting that some of the benefit may be related to non-specific (placebo) mechanisms. Acupuncture is listed as an option in ACP and NICE guidelines but is best used as a complement to exercise and active self-management, not as a standalone treatment.
Q5: When should I see a doctor for low back pain? A5: Seek immediate medical attention if you experience loss of bladder or bowel control, numbness in the groin/saddle area, severe or progressive weakness in one or both legs, or back pain after significant trauma. Schedule a non-urgent appointment if your pain persists beyond 4–6 weeks despite self-care, if it radiates below the knee, or if you have systemic symptoms such as unexplained weight loss or fever [7].
References
[1] Johnson MI, Paley CA, Jones G et al. BMJ Open 2022. PMID:35144946. pubmed.ncbi.nlm.nih.gov/35144946
[2] Du R, Xu G, Bai X. Journal of Pain Research 2022. PMID:36474960. pubmed.ncbi.nlm.nih.gov/36474960
[3] Vleeming A, Albert HB, Ostgaard HC et al. European Spine Journal 2008. PMID:18259783. pubmed.ncbi.nlm.nih.gov/18259783
[4] Mu J, Furlan AD, Lam WY et al. Cochrane Database of Systematic Reviews 2020. PMID:33306198. pubmed.ncbi.nlm.nih.gov/33306198
[5] Bagg MK, Wand BM, Cashin AG et al. JAMA 2022. PMID:35916848. pubmed.ncbi.nlm.nih.gov/35916848
[6] Cahueque M, Ardebol J, Armas J. Acta Ortopédica Mexicana 2021. PMID:34480446. pubmed.ncbi.nlm.nih.gov/34480446
[7] Maharty DC, Hines SC, Brown RB. American Family Physician 2024. PMID:38574213. pubmed.ncbi.nlm.nih.gov/38574213
[8] Abd-Elsayed A, Kurt E, Kollenburg L et al. Pain Practice 2025. PMID:40361257. pubmed.ncbi.nlm.nih.gov/40361257
About the author
Dr. Stanislav Ozarchuk, PharmD, has 15 years of clinical pharmacy experience. He writes for PillsCard.com, the international drug encyclopedia.
Medical disclaimer
The information provided here is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.